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A Novel Nonsense Mutation in CEP290 Induces Exon
Skipping and Leads to a Relatively Mild Retinal Phenotype
Karin W. Littink,1,2 Jan-Willem R. Pott,3 Rob W. J. Collin,2,4,5 Hester Y. Kroes,6
Joke B. G. M. Verheij,7 Ellen A. W. Blokland,2 Marta de Castro Miro´,2 Carel B. Hoyng,5
Caroline C. W. Klaver,8,9 Robert K. Koenekoop,10 Klaus Rohrschneider,11
Frans P. M. Cremers,2,4 L. Ingeborgh van den Born,1 and Anneke I. den Hollander4,5
PURPOSE. To identify the genetic defect in a family with variable
retinal phenotypes. The proband had a diagnosis of Leber
congenital amaurosis (LCA), whereas her two cousins had an
early-onset severe retinal dystrophy (EOSRD) with useful vi-
sion. A distant family member had retinitis pigmentosa (RP).
METHODS. DNA samples of the affected family members were
genotyped with 250 K genome-wide SNP microarrays. Genetic
defects were localized by linkage analysis and homozygosity
mapping, and candidate genes were analyzed by sequencing.
Patients underwent a full ophthalmic examination.
RESULTS. Compound heterozygous mutations in CEP290 were
identified in the proband and her two cousins: the frequent
c.29911655AG founder mutation and a novel nonsense
mutation in exon 7 (c.451CT, p.Arg151X). The proband had
nystagmus, hyperopia, a flat electroretinogram (ERG), and de-
creased visual acuity (20/250) from birth. The two cousins had
minimal scotopic ERG responses at the age of 2. In one of these
patients, visual acuity had reached a level of 20/32 at age 5,
which is high for patients with CEP290 mutations. Analysis of
the CEP290 mRNA in affected individuals revealed altered
splice forms in which either exon 7 or exons 7 and 8 were
skipped. In both mutant cDNA products, the open reading
frame was not disrupted. Furthermore, homozygosity mapping
and mutation analysis in the distant family member affected by
RP revealed a homozygous mutation in MERTK, but no
CEP290 mutations. This MERTK mutation was heterozygously
present in the most severely affected (LCA) patient, but was
absent in the two more mildly affected cousins.
CONCLUSIONS. A novel nonsense mutation in CEP290 results in
nonsense-associated altered splicing. That the remaining open
reading frame is intact may explain the less severe phenotype
observed in the two affected cousins. The additional heterozy-
gous mutation in MERTK may clarify the more severe pheno-
type in the proband. This study extends the phenotypic spec-
trum of CEP290-associated diseases at the mild end. (Invest
Ophthalmol Vis Sci. 2010;51:3646–3652) DOI:10.1167/iovs.09-
5074
Mutations in CEP290 cause a broad spectrum of diseases,ranging from Meckel-Gruber syndrome (MKS), a lethal
multisystemic disorder, and Joubert syndrome (JBTS) at the
more severe end, to Leber congenital amaurosis (LCA), at the
milder end of the clinical spectrum.1–5 In addition, several
families with Senior Løken syndrome (SLSN) and one case of
Bardet-Biedl syndrome (BBS) have been associated with muta-
tions in CEP290.6,7 The CEP290 protein encodes a ciliary and
centrosomal protein that is present in cells of different tissues,
explaining the variable set of symptoms, including renal abnor-
malities (MKS, JBTS, SLSN, and BBS), neurologic abnormalities
(MKS, JBTS, and BBS), retinal degeneration (JBTS, SLSN, BBS,
and LCA), and polydactyly (MKS and BBS).
CEP290-associated LCA is a single-organ disease affecting
the retina.4,5 Mutations in CEP290 are the most common cause
of LCA, responsible for up to 6% to 22% of cases.4,5,8,9 A
founder mutation in intron 26 (c.29911655AG), leading to
the insertion of a cryptic exon with a premature stop codon, is
the most prevalent CEP290 mutation in LCA patients.4,10 Since
a fraction of wild-type CEP290 mRNA remains in patients
carrying the intronic mutation, it is hypothesized that this
hypomorphic character of the mutation explains why the mu-
tation leads to LCA, instead of a multiorgan disease.4 The
CEP290-associated retinal phenotype is classified by Perrault et
al.5 as a cone–rod type of LCA (type I as classified by Hanein et
al.11), with visual acuity of 20/400 or lower, high hyperopia
(6 or more), slight photo aversion, and a salt-and-pepper
appearance of the retina, with macular degeneration in the first
decade, changing to the typical appearance of retinitis pigmen-
tosa (RP) at later stages.5
In this study, we examined three patients with a LCA-like
phenotype. However, two of them retained useful vision, and
we therefore classified their disease as early-onset severe reti-
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nal dystrophy (EOSRD), which is considered to be milder than
LCA. The less severe phenotype is caused by a novel nonsense
mutation that induces exon skipping without disrupting the
open reading frame. In addition, we report on the finding that
one individual with the same set of CEP290 variants showed an
LCA phenotype, which may be caused by the cumulative effect
of a heterozygous MERTK frameshift mutation.
METHODS
This study was approved by the ethics review board of The Rotterdam
Eye Hospital and adhered to the tenets of the Declaration of Helsinki.
Informed consents were signed by all participants and, in the case of
minors, by their parents.
Clinical Evaluation
The affected individuals (VI-3, VI-4, and VI-6; Fig. 1) visited the Uni-
versity Medical Centre Groningen for the first time at the age of 6
months and were seen for follow-up examinations regularly thereafter
for up to 11 years. The examinations included electroretinograms
(ERGs), recorded according to the protocol of the International Society
for Clinical Electrophysiology of Vision (ISCEV).12 The three patients
were re-evaluated at The Rotterdam Eye Hospital recently. Parents
were extensively interviewed about the medical history of their chil-
dren. Clinical evaluation included best corrected visual acuity using
ETDRS charts and was expressed as Snellen equivalents, objective
refractive error after cycloplegia, biomicroscopy, and fundoscopy.
Visual fields were assessed with Goldmann kinetic perimetry (targets
V-4e to I-4e for patients VI-3 and VI-4, and V-4e to II-4e for patient VI-6).
Color vision was tested with the American Optical Hardy-Rand-Rittler
Test (AO-HRR) and the Farnsworth Panel D-15 Test (saturated and
desaturated) in all patients and by the Ishihara Test for Color Blindness
in patient VI-4. Additional tests included fundus photography and
spectral domain optical coherence tomography (OCT; Spectralis; Hei-
delberg Engineering, Heidelberg, Germany) for evaluating the in vivo
retinal structure. Autofluorescence images (30°) were obtained with a
confocal scanning laser ophthalmoscope with 488-nm excitation (Reti-
nogram Angiograph 2; Heidelberg Engineering, Heidelberg, Germany)
to detect alterations of the retinal pigment epithelium and lipofuscin
accumulation. Kidney function was assessed by serum analyses of
sodium, potassium, and creatinine levels. A magnetic resonance imag-
ing (MRI) scan of the brain was performed in patient VI-3 to exclude
brain abnormalities, including the molar tooth sign typical of JBTS.
Electroretinography was repeated in patient VI-3.
Ophthalmic examination and ERG were also performed in the
parents to search for clinical abnormalities in mutation carriers.
Molecular Genetic Analysis
Blood samples for molecular genetic analysis were obtained from all
family members (Fig. 1). Total genomic DNA was extracted from
leukocytes by a standard salting-out procedure.12 DNA samples of the
affected subjects, including a distant family member affected by RP
(VI-3, VI-4, VI-6, and V-1; Fig. 1), were genotyped for 262,000 single-
nucleotide polymorphisms (SNPs; GeneChip Mapping 250K NspI ar-
ray; Affymetrix, Santa Clara, CA). Array experiments were performed
according to protocols provided by the manufacturer. Multipoint link-
age analysis was performed with GeneHunter ver. 2.1r513 in the
easyLINKAGE-Plus software package,14 with use of the Caucasian allele
frequencies. Homozygosity mapping was performed with the software
package CNAG.15
Mutation analysis of the CEP290 gene was performed using previ-
ously described PCR primers and conditions.1 Primers for the MERTK
gene were designed by using primer3 software16 and are listed to-
gether with the PCR conditions in Supplementary Table S1, http://
www.iovs.org/cgi/content/full/51/7/3646/DC1. Direct sequencing
was performed in sense and antisense direction on an automated
sequencer (BigDye Terminator, ver. 3, model 3730 DNA analyzer;
Applied Biosystems, Inc. [ABI], Foster City, CA). Segregation analysis of
the CEP290 and MERTK mutations in all family members was per-
formed by sequencing. Eighty-five LCA patients and 123 patients af-
fected by cone–rod dystrophy (CRD) were screened for the CEP290
c.29911655AG mutation by allele-specific PCR17 and for the
p.Arg151X mutation by restriction fragment length polymorphism
analysis using TaqI (ABI; Supplementary Table S1).
To determine the effect of p.Arg151X on the CEP290 mRNA level,
we collected blood samples (PAX vials; Qiagen, Venlo, The Nether-
FIGURE 1. Pedigree with inherited
retinal diseases and pathologic
CEP290 and MERTK variants. The
proband (VI-6; arrow) is affected by
LCA, two cousins (VI-3 and VI-4) are
affected by EOSRD, and one distant
family member (V-1) is affected by
RP. Mutations in CEP290 and
MERTK are indicated. For reasons of
privacy, mutations in the unaffected




type); and M3, MERTK c.1179dup,
p.Leu394SerfsX3.
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lands) of the three affected children (VI-3, VI-4, and VI-6, Fig. 1) and six
control individuals and isolated the RNA (PAXgene Blood RNA kit 50
ver. 2; Qiagen), according to the protocol provided by the manufac-
turer. Total RNA (1.5 g) was reverse transcribed to cDNA with M-MLV
reverse transcriptase (Invitrogen, Breda, The Netherlands). RT-PCR
experiments were performed on 2.5 L of synthesized cDNA or human
retina Marathon-Ready cDNA (Clontech, Temecula, CA), with primers
in exon 5 and 10 (35 cycles), followed by nested PCR on 0.5 L, with
the same forward primer in exon 5 and a reverse primer in exon 9 (15
cycles; Supplementary Table S1).
RESULTS
Clinical Features
Individuals VI-3, VI-4, and VI-6 visited the ophthalmologist
within 6 months after birth because of nystagmus and lack of
fixation. Ophthalmic assessment revealed a vertical nystagmus,
normal pupil responses, a high hyperopia, and essentially nor-
mal-appearing fundi. In all three individuals, ERG was per-
formed at the age of 2 years. In patient VI-6, both scotopic and
photopic responses were nonrecordable. In patients VI-3 and
VI-4, photopic responses were nonrecordable, whereas the
scotopic responses were severely reduced, but measurable
(15% of normal values). Patient VI-3 was evaluated by a pedi-
atric neurologist because of the vertical nystagmus, but intra-
cranial abnormalities were excluded by neurologic assessment
and by an MRI scan of the brain. The patients’ histories did not
reveal any abnormalities about pregnancy and delivery. Beside
the ophthalmic symptoms, no other abnormalities in motor or
cognitive development were reported, and their intelligence
was normal.
An overview of the most recent clinical data are presented
in Table 1. In summary, all three patients experienced night
blindness and no photophobia. Patients VI-4 and VI-6 displayed
mild exotropia. Visual acuity varied from 20/40 in the best eye
of patient VI-3 to 20/125 in patient VI-4 and 20/250 in patient
VI-6 at ages 11, 8, and 9, respectively (Fig. 2). On funduscopy
the posterior retina was relatively well preserved in all three
patients, with pink optic discs with a scleral rim, attenuated
retinal vasculature, and subtle retinal pigment epithelium
(RPE) changes in the macular region. In patient VI-3, we found
the remnants of a tapetal reflex that had a marbled appearance.
This reflex was more pronounced at the age of 5 years and was
documented on fundus photographs (Figs. 3A, 3B). In the far
periphery, subretinal pigmentations were noted in patients
VI-3 and VI-4. The periphery in patient VI-6 had a very hypo-
pigmented appearance with intraretinal bone spicule pigmen-
tations (Fig. 3E). Visual fields were constricted in all patients,
but most severely in VI-6, who was also not able to perform a
color vision test. On OCT a preserved photoreceptor layer was
noted in the posterior pole in the two patients tested (VI-3 and
VI-4; Fig. 3D). Autofluorescence images, which were difficult
to obtain because of the nystagmus, showed a mildly reduced
intensity of the signal in the posterior pole and midperiphery,
with a normal decrease of intensity at the macular region in all
three individuals (Fig. 3C).
Altogether, the phenotype of the proband (VI-6) was most
similar to LCA. The phenotype of the two more mildly affected
cousins (VI-3 and VI-4) was classified as EOSRD, to emphasize
the fact that they were less severely affected.
Ophthalmic examination did not reveal abnormalities in
three of four heterozygous carrier parents. In one parent, we
detected a choroidal melanoma (V-2, see Fig. 1). The ERG
responses were in the high range of normal in three of the
parents (V-3, V-4, and V-5) and completely normal in parent
V-2.
Molecular Genetics
Genome-wide linkage analysis was performed on DNA of the
proband (VI-6) and her two cousins (VI-3 and VI-4). The family,
originating from a northern province in The Netherlands, was
reported to be nonconsanguineous. However, the patients
were related through both parental lineages: They were first
cousins through one parent and fourth cousins through the
other (Fig. 1). Linkage analysis revealed only one significant
chromosomal region, which localizes between SNPs
rs10879550 and rs1579244 on 12q21.1-q23.1, with a LOD
score of 2.4. The region harbors 68 genes, among which we
found CEP290, making this the most obvious candidate gene in
this family. Mutation analysis of the CEP290 gene revealed a
compound heterozygous combination of the most common
CEP290 founder mutation in intron 26 (c.29911655AG)4
and a novel nonsense mutation in exon 7 (c.451CT;
p.Arg151X). The mutations segregate with the disease in the
family (Fig. 1). The deep intronic c.29911655AG variant
creates a functional 5 splice site and the insertion of a cryptic
exon into approximately 50% of the CEP290 mRNA.4 The
cryptic exon contains a nonsense codon (p.Cys998X), re-
sulting in a predicted truncation of the CEP290 protein. As
50% of the CEP290 mRNA remains wild-type, the
c.29911655AG variant can be considered a hypomorphic
change.4
Because patients VI-3 and VI-4 had residual rod function
and nondetectable cone ERGs at the age of 2 years, we
screened 123 patients affected by CRD for both these
CEP290 mutations. In addition, 85 LCA patients in whom
the c.29911655AG mutation was previously excluded4
were screened for the p.Arg151X mutation. The
c.29911655AG and p.Arg151X mutations were not de-
tected in additional CRD or LCA probands. The novel
p.Arg151X mutation was also excluded in 182 alleles of
ethnically matched control subjects.
Usually, the combination of a hypomorphic change and a
truncating change would lead to an LCA phenotype. Since the
phenotypes in VI-3 and VI-4 were much less severe than typical
LCA, we hypothesized that the p.Arg151X mutation should
have a hypomorphic character. Therefore, using RT-PCR we
analyzed CEP290 mRNA in peripheral blood lymphocytes of
the affected children (VI-3, VI-4, and VI-6) and six control
individuals. Although splice site and exonic splice enhancer
site prediction software18,19 did not predict an effect on the
splicing process, we identified three different RT-PCR products
in heterozygous carriers of p.Arg151X when using a forward
primer in exon 5 and a reverse primer in exon 10. One product
represented normally spliced mRNA, in which only a minimal
fraction of the mutated T-allele was present (Fig. 4C). The
second PCR product (282 bp) lacked exon 7, and the third
product (261 bp) lacked exons 7 and 8 (Fig. 4). The removal of
exon 7 or exons 7 and 8 does not disrupt the open reading
frame. These alternatively spliced products were not detected
in six control individuals. It was also not present in human
retina cDNA (data not shown). In patients as well as control
individuals, we found a weak-intensity PCR product lacking
exon 6.
Homozygosity mapping in the distantly related RP patient
(V-1; Fig. 1) revealed several homozygous segments (Collin et
al., manuscript in preparation). Sequence analysis of MERTK, a
known RP gene located within the patient’s largest homozy-
gous region, revealed a homozygous frameshift mutation
(c.1179dup, p.Leu394SerfsX3). This mutation was identified
heterozygously in the most severely affected (LCA) patient
(VI-6) and was not identified in the more mildly affected
(EOSRD) patients (VI-3 and VI-4; Fig. 1).
3648 Littink et al. IOVS, July 2010, Vol. 51, No. 7
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DISCUSSION
Using linkage analysis in a family with one proband affected by
LCA and her two cousins affected by EOSRD, we localized the
genetic defect on 12q21 and detected compound heterozy-
gous mutations in CEP290 (c.29911655AG and c.451CT,
p.Arg151X). The intronic mutation is known as the most prev-
alent LCA-causing mutation in CEP290.4,5 The nonsense muta-
tion p.Arg151X has not been described before. The phenotype
of the LCA patient was comparable to the CEP290-LCA patients
previously described4,5 and consisted of nystagmus, high hy-
peropia (4.5 D), night blindness, reduced visual acuity from
birth (20/250), fundus abnormalities, and nonrecordable elec-
trophysiological responses. The phenotypes of the two af-
fected cousins were comparable, but less severe, with minimal
measurable scotopic responses on ERG and a more functional
visual acuity. Lorenz et al.20 coined the name early-onset severe
rod–cone dystrophy to distinguish between true LCA and rel-
atively less severe phenotypes as, for example, observed in
patients carrying mutations in RPE65. Comparably, we decided
that the classification EOSRD would be a more appropriate
description of the phenotype of the two affected cousins.
That we found a remnant of rod function at the age of 2
years in these two patients suggests that CEP290-associated
LCA is of the cone–rod type as observed by Perrault et al.5 On
the other hand, visual acuity and color vision were relatively
well preserved, suggesting the opposite. An interesting finding
was the marbled appearance of the fundi, which seemed to
disappear with age, in patient VI-3. A similar appearance of the
FIGURE 2. Visual acuity of patients with EOSRD and LCA. The course
of visual acuity is shown in decimals (y-axis) with age (x-axis) in
patients VI-3 and VI-4 (EOSRD) and patient VI-6 (LCA). The improve-
ment in visual acuity at age 5 in patient VI-3 is most likely the effect of
better performance at visual acuity assessment.
FIGURE 3. Retinal imaging of patients VI-3 and VI-6. (A) Photograph of
the midperipheral fundus of patient VI-3 at the age of 5, showing a
marbled appearance. (B) Fundus photograph of the same patient VI-3
at the age of 11, which shows that the marbled appearance had
disappeared, and mild atrophy of the RPE was noted. (C) Mean
autofluorescence image (30°) of the left eye of patient VI-3, calculated
from 12 single images (488 nm), showing a well preserved signal in the
posterior pole with decreased intensity in the macular region. (D)
Spectral domain OCT of the left eye of patient VI-3 at the age of 11
shows a recognizable photoreceptor layer, intact retinal layers, and
disappearance of the foveal dimple. (E) Fundus photograph of left eye
of patient VI-6, showing preserved RPE in the macular region with an
extremely hypopigmented area along the vascular arcade, which ex-
tends to the periphery.
FIGURE 4. CEP290 cDNA analysis of the effect of the c.451CT vari-
ant on splicing. (A) Agarose (3%) gel electrophoresis showing three
major PCR products in carriers of p.Arg151X and one major product in
the six control individuals. (B) Agarose gel electrophoresis showing
GUSB as the reference gene product. (C–E) PCR sequences of cDNA of
patient VI-3 (CEP290 c.451CT/c.29911655AG), showing (C)
mRNA containing all exons, but showing a low peak for the mutant
heterozygous T at position 451 (arrow). (D) mRNA missing exon 7,
and (E) mRNA missing exons 7 and 8. *Low-intensity product could not
be amplified for sequence analysis. Based on the size, it could contain
the CEP290 mRNA lacking exon 8 only, which should be 315 bp;
†low-intensity product 200 bp was analyzed by sequence analysis
and appeared to be the CEP290 mRNA lacking exon 6 only (192 bp).
Since CEP290 lacking exon 6 is present in patients as well as control
individuals, it appears to be a normal splice variant.
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fundus was seen in two other patients carrying mutations in
CEP290 (L. Ingeborgh van den Born, personal observation).
Perrault et al.5 showed a similar fundus as well and called it
“white dots.” The etiology of this fundus abnormality remains
unclear, but tapetal reflexes can be pathognomonic for certain
diseases, as has been observed in carriers of RPGRmutations.21
The marbled appearance of the fundus may be pathognomonic
for the CEP290-associated phenotype.
In contrast to the previously described CEP290-associated
phenotype, we determined a visual acuity that is remarkably high
compared with most patients carrying mutations in CEP290,
especially in patient VI-3 (20/40 at age 11). Awell-preserved visual
acuity has been reported previously in 4 patients of the 77
CEP290-LCA patients who have been described clinically (18
patients from Yzer et al., manuscript in preparation).4,5,10 Three
patients carried the c.29911655AG variant homozygously and
had visual acuities of 20/80 and 20/150 at age404 and 20/50 at
age 20.10 One patient carried the c.29911655AG mutation
together with a c.5668GT (p.Gly1890X) nonsense mutation and
had visual acuity of 20/50 at age 19.10 In most patients, however,
the visual acuity ranged from no vision at birth to a maximum of
20/400, as shown in 47 patients by Perrault et al.5 and in the 18
patients evaluated by Yzer et al. (manuscript in preparation).5 We
hypothesize that the mild phenotype in the two cousins de-
scribed in this study can be explained by the fact that they carry
two mutations with a relatively mild effect on the protein. First,
the c.29911655AG mutation affects only part of the mRNA;
part of the wild-type mRNA remains present as shown by den
Hollander et al.4 Second, the allele carrying the p.Arg151X muta-
tion is differentially spliced, lacking exon 7 or exons 7 and 8, but
remain in frame. The low peak of the mutated T nucleotide in the
mRNA (Fig. 4) shows that most of the differentially spliced
CEP290 results from the mutated allele. Usually, the presence of
a premature termination codon (PTC) leads to nonsense-mediated
mRNA decay, a process that results in the degradation of non-
sense-containingmRNAs.22–24We suggest that the different splice
products are the result of nonsense-associated altered splicing
(NAS), a putative correction mechanism that recognizes an exon
with a PTC, and excludes that exon from the mature mRNA.25–28
One form of NAS is due to the disruption of an exonic splice
enhancer (ESE) by a mutation. Since the ESE finder program19
does not predict a disruption of an ESE, NAS is likely to occur
specifically due to the nonsense character of the p.Arg151X mu-
tation. The precise mechanism is not well understood yet.29
Exons 3 to 17 of the CEP290 protein are predicted to encode a
coiled-coil domain of 506 amino acids. The protein sequences
lacking the 18 or 25 amino acids encoded by exon 7 or by exons
7 and 8 are still predicted to encode a coiled-coil domain that is
only slightly shorter than the wild-type coiled-coil domain. There-
fore, we hypothesize that the altered spliced products encode a
stable protein with residual function, resulting in a relatively mild
phenotype. Because of technical limitations, it is difficult to quan-
tify the amount of mutant mRNA that is subjected to NAS. Since
the mutant splice products are smaller than the wild-type prod-
uct, theywill be amplifiedmore efficiently. In addition, we cannot
be certain that the analysis of lymphoblast mRNA is representative
of the in vivo situation in the retinas of these patients.
The three patients in this study showed an intrafamilial
phenotypic variability that led to different clinical diagnoses.
Intrafamilial variability has been reported before in a family
with four patients carrying homozygous c.29911655AG
mutations.4 Since the amount of wild-type CEP290 product,
quantified in lymphoblast RNA, was comparable in all patients
of that family (data not shown), another variant in other
gene(s) may influence the phenotype and the intrafamilial
variability. In the family described in this study, the intrafamil-
ial variability between the proband and her two cousins may
be explained by the heterozygous p.Leu394SerfsX3 mutation
in the MERTK gene, which was present in the LCA patient
(VI-6) and absent in the two EOSRD patients (VI-3 and VI-4).
MERTK is associated with autosomal recessive RP30–32 and is
strongly expressed in the RPE and macrophages, where it plays
a role in the RPE phagocytosis process.33 CEP290 is localized in
the connecting cilia of photoreceptors and is suggested to play
a role in microtubule-associated protein transport in the
cilia.2,3,34 In view of the difference in function and localiza-
tion, a physical interaction between these proteins seems un-
likely. Moreover, one MERTK p.Leu394SerfsX3 mutation and
one CEP290 c.29911655AG mutation together do not lead
to symptoms of retinal dystrophy (in individual V-4). In addi-
tion, human and murine carriers of heterozygous pathogenic
MERTK mutations do not show signs of retinal dystrophy as
well. However, cultured RPE cells from the RCS rats that carry
a homozygous truncating deletion in MERTK in vitro phagocy-
tose only a few photoreceptor outer segments, in contrast to
wild-type cells, in which many phagosomes appear.35 There-
fore, RPE cells with only 50% of the amount of functional MER
tyrosine kinase receptor may have a lower turnover of photo-
receptor outer segment phagocytosis, which does not have a
measurable pathogenic effect in otherwise healthy individuals,
but could have a cumulative (or modifying) effect in patients in
whom the production of photoreceptor outer segments is
disturbed, in this case by two pathogenic mutations in
CEP290. The phenomenon of modifier alleles has been de-
scribed—for example, tri-allelic mutations resulting in a more
severe phenotype in Bardet-Biedl patients and a modifier
RPGRIP1L allele that is suggested to result in a more severe
retinal phenotype in ciliopathies.36,37 Nevertheless, it remains
speculative whether the MERTK mutation functions as a mod-
ifier allele. The a priori chance for an individual to carry a
pathogenic mutation in a retinal dystrophy gene is 10%,
assuming that there are 67 autosomal recessive retinal dystro-
phy genes that all account for a similar proportion of cases, as
calculated by Rivolta et al.38 in 2002. Currently, 44 nonsyn-
dromic autosomal recessive retinal dystrophy genes have been
identified (http://www.sph.uth.tmc.edu/retnet/ University of
Texas Houston Health Science Center, Houston, TX) that ac-
count for 50% of cases, indicating that the calculation of
Rivolta et al. could be realistic. Therefore, we estimate that 10%
of retinal dystrophy patients are expected to carry a heterozy-
gous mutation in a second gene. Eventually, the identification
of combinations of mutations in more than one retinal dystro-
phy gene by next-generation sequencing, together with a pre-
cise description of phenotypes, may uncover the unknown
influences of additional heterozygous mutations.
In conclusion, we found a novel nonsense mutation in exon
7 of CEP290 that causes a milder phenotype than expected for
an early nonsense mutation, most likely due to nonsense-
associated altered splicing. Furthermore, we detected a het-
erozygous MERTK mutation in the most severely affected pa-
tient that may have a deteriorating effect on the phenotype. In
this study, we extended the phenotypic spectrum of CEP290-
associated diseases at the mildest end.
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